Arkolith/Insider Trading/AARD/Form 4

Sun Nelson

Chief Financial OfficerAardvark Therapeutics, Inc. (AARD) · full profile →Form 4 · filed Dec 12, 2025
Net Buying
Open-Market Buys
$43K
Open-Market Sells
$0
Net Open-Market Flow
$43K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 11, 2025Buy(P)3K$14.40$43K108K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-318070) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML